Author:
Haitz Kassie A.,Kalb Robert E.
Reference30 articles.
1. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment;Koo;Dermatol Clin,1996
2. Binding and functional comparisons of two types of tumor necrosis factor antagonists;Scallon;J Pharmacol Exp Ther,2002
3. Tyring S, Poulin Y, Langley R, Gordon K. A 96-week phase 3 study of safety and efficacy of etanercept 50 mg twice weekly in patients with psoriasis. Poster P39 presented at: Annual Meeting of the American Academy of Dermatology; March 4, 2006; San Francisco, CA.
4. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicenter, double-blind trial;Reich;Lancet,2005
5. A randomized comparison of continuous vs intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis;Menter;J Am Acad Dermatol,2007
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献